Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed transactions. The firm is examining whether insiders are receiving unfair benefits and whether deal terms limit competing offers. The investigations cover Tri Pointe Homes' sale to Sumitomo Forestry, Stellar Bancorp's sale to Prosperity Bancshares, Devon Energy's merger with Coterra Energy, and Marine Products' sale to MasterCraft Boat Holdings.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties. The investigations concern MasterCraft Boat Holdings' merger with Marine Products Corporation, SkyWater Technology's sale to IonQ, Marine Products' sale to MasterCraft, and SunOpta's sale to Refresco. The firm is seeking increased consideration, additional disclosures, and other relief on behalf of shareholders.

Monteverde & Associates PC, a class action law firm, is investigating four merger and acquisition transactions: MasterCraft Boat Holdings' merger with Marine Products Corporation, SunOpta's sale to Pegasus BidCo B.V., Marine Products' sale to MasterCraft, and SkyWater Technology's sale to IonQ. The firm is seeking shareholders who have concerns about these proposed transactions.

Marine Products Corporation (NYSE: MPX) announced a regular quarterly cash dividend of $0.14 per share, payable on March 10, 2026, to shareholders of record as of February 10, 2026.

Marine Products reported Q2 2025 earnings with a 3% decline in net sales to $67.7 million, primarily due to a 13% drop in boat unit sales, though partially offset by a 10% price/mix gain. The company maintains a strong cash position of $50.2 million with no debt and continues to focus on inventory management and product innovation.

Marine Products Corporation reported a 33% year-over-year decrease in Q4 2024 net sales to $47.8 million, with net income down 21% to $4.3 million. The company cited continued soft order flow and high dealer inventories, but expects sales comparisons to be flat in the near-term with potential for growth in the second half of 2025.

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion. Humana shares dipped 11.3% to $356.93 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Onconetix, Inc. (NASDAQ: ONCO) shares surged 137% to $0.3519 after falling over 4% on Wednesday. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Enviva Inc. (NYSE: EVA) climbed 47.4% to $0.5239. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Rail Vision Ltd. (NASDAQ: RVSN) gained 43.8% to $7.78. Foresight's affiliate Rail Vision's Main Line System secured EU Railway Standards approval and certifications. LAVA Therapeutics N.V. (NASDAQ: LVTX) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in combination with KEYTRUDA. Acutus Medical, Inc. (NASDAQ: AFIB) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health)." Prairie Operating Co. (NASDAQ: PROP) gained 28.8% to $8.17. American Superconductor Corporation (NASDAQ: AMSC) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates. CCSC ...

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. Fisker Inc. (NYSE: FSR) Fisker plans to report its earnings release after the closing bell on Nov. 13, 2023. The company’s stock has a 52-week low of $3.68 . RSI Value: 29.70 FSR Price Action: Shares of Fisker gained 1.3% to close at $3.84 on Friday. Fox Factory Holding Corp. (NASDAQ:

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash. Eargo, Inc. (NASDAQ: EAR) shares climbed 50.4% to $2.5274 after the company announced it will be taken private by Patient Square Capital. VYNE Therapeutics Inc. (NASDAQ: VYNE) gained 39.9% to $3.1399 after the company announced a private placement of $88 million and data from its Phase 1b trial evaluating once-daily dosing of VYN201 in patients with nonsegmental vitiligo. Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares gained 27.9% to $1.3042 after falling more than 12% on Friday. HeartCore Enterprises, Inc. (NASDAQ: HTCR) surged 24% to $0.7718. Heartcore Enterprises recently entered into at-market offering agreement for an at-market offering with H.C. Wainwright & Co. ImmunityBio, Inc. (NASDAQ: IBRX) gained 19.4% to $2.9600. The FDA recently accepted ImmunityBio's resubmission of its Biologics License Application for N-803 as complete. Coherus BioSciences, Inc. (NASDAQ: CHRS) shares climbed 16.8% to $3.0850. Coherus and Junshi Biosciences reported FDA approval of LOQTORZI in all lines of treatment for recurrent or metastatic nasopharyngeal carcinoma. Aemetis, Inc. (NASDAQ: AMTX) gained 16.5% to $5.02. Aemetis received $150 million biodiesel supply allocation from India oil marketing companies. JinkoSolar Holding Co., Ltd. (NYSE: JKS) surged 16% to $30.01 following better-than-expected quarterly results. Akerna Corp. (NASDAQ: KERN) jumped 16% to $0.3550. MeiraGTx Holdings plc (NASDAQ: MGTX) rose 16% to $4.29. MeiraGTx announced a $30 million strategic investment from Sanofi via purchase of 4 million shares at $7.50 per share. Motus GI ...

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. Nuvve Holding Corp. (NASDAQ: NVVE) shares climbed 88% to $0.2789 after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million shares of common stock at a price to the public of $0.14 per share. BIO-key International, Inc. (NASDAQ: BKYI) surged 57% to $0.30. BIO-key International reported results for its third quarter ended Sept. 30, 2023. ReShape Lifesciences Inc. (NASDAQ: RSLS) gained 44.7% to $0.2976 after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million public offering. BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares climbed 37.6% to $3.2199 after announcing positive findings from an independent third party audit of the data integrity at TRANQUILITY II Phase 3 trial site. ParaZero Technologies Ltd. (NASDAQ: PRZO) gained 26% to $2.0350. Catalyst Biosciences, Inc. (NASDAQ: CBIO) climbed 18% to $0.5095. Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 16.5% to $8.92. Jefferies upgraded Scholar Rock from Hold to Buy and announced a $20 price target. Stride, Inc. (NYSE: LRN) rose 16.4% to $51.81 after the company reported first-quarter results. OncoCyte Corporation (NASDAQ: OCX) gained 14.4% to $2.86. Urgent.ly Inc. (NASDAQ: ULY) surged 14% to $5.01. GameSquare Holdings, Inc. (NASDAQ: GAME) gained 13.1% to $2.07. Treasure Global Inc. (NASDAQ: TGL) rose 12.8% to $0.4501. PROG Holdings, Inc. (NYSE: PRG) rose 9.3% to $31.14 following upbeat quarterly results. LumiraDx Limited (NASDAQ: LMDX) gained 8.4% to $0.1680 after dipping around 44% on Tuesday. John Bean Technologies Corporation (NYSE: JBT) surged 8.1% to $104.00 after posting strong quarterly earnings. Sonendo, Inc. (NYSE: SONX) shares gained 8% to $0.2483 after falling over 23% on Tuesday. Sonendo recently announced preliminary revenue results for the third quarter. Crown ElectroKinetics Corp. (NASDAQ: CRKN) climbed 8% to $0.2700. Deutsche Bank Aktiengesellschaft (NYSE: DB) rose 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. Deutsche Bank Aktiengesellschaft (NYSE: DB) gained 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. The Gap, Inc. (NYSE: GPS) climbed 6.2% ...

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?